Selected research
Market Outlook & Growth Opportunities
Global Whole Genome Resequencing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Whole Genome Resequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Whole Genome Resequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Whole Genome Resequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Whole Genome Resequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Whole Genome Resequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Whole Genome Resequencing Service market include Macrogen, GENEWIZ, Eurofins Genomics, GATC Biotech, Otogenetics Corporation, SeqWright, Personalis Inc., Psomagen and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Whole Genome Resequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Whole Genome Resequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Whole Genome Resequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Whole Genome Resequencing Service market.
Whole Genome Resequencing Service Segment by Company
Macrogen
GENEWIZ
Eurofins Genomics
GATC Biotech
Otogenetics Corporation
SeqWright
Personalis Inc.
Psomagen
Illumina
BGI Genomics
Novogene
Whole Genome Resequencing Service Segment by Type
Human Whole Genome Resequencing
Animal Whole Genome Resequencing
Plant Whole Genome Resequencing
Whole Genome Resequencing Service Segment by Application
Evolutionary Studies
Molecule Breeding
Physiological Mechanism
Whole Genome Resequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Whole Genome Resequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Whole Genome Resequencing Service key companies, revenue, market share, and recent developments.
3. To split the Whole Genome Resequencing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Whole Genome Resequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Whole Genome Resequencing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Whole Genome Resequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Genome Resequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Genome Resequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Genome Resequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Genome Resequencing Service industry.
Chapter 3: Detailed analysis of Whole Genome Resequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Whole Genome Resequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Whole Genome Resequencing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Whole Genome Resequencing
- Animal Whole Genome Resequencing
- Plant Whole Genome Resequencing
Applications
- Evolutionary Studies
- Molecule Breeding
- Physiological Mechanism
Companies covered
- Macrogen
- GENEWIZ
- Eurofins Genomics
- GATC Biotech
- Otogenetics Corporation
- SeqWright
- Personalis Inc.
- Psomagen
- Illumina
- BGI Genomics
- Novogene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Whole Genome Resequencing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Whole Genome Resequencing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Whole Genome Resequencing Service Market Dynamics
- 2.1 Whole Genome Resequencing Service Industry Trends
- 2.2 Whole Genome Resequencing Service Industry Drivers
- 2.3 Whole Genome Resequencing Service Industry Opportunities and Challenges
- 2.4 Whole Genome Resequencing Service Industry Restraints
3 Whole Genome Resequencing Service Market by Company
- 3.1 Global Whole Genome Resequencing Service Company Revenue Ranking in 2025
- 3.2 Global Whole Genome Resequencing Service Revenue by Company (2021-2026)
- 3.3 Global Whole Genome Resequencing Service Company Ranking (2024-2026)
- 3.4 Global Whole Genome Resequencing Service Company Manufacturing Base and Headquarters
- 3.5 Global Whole Genome Resequencing Service Company Product Type and Application
- 3.6 Global Whole Genome Resequencing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Whole Genome Resequencing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Whole Genome Resequencing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Whole Genome Resequencing Service Market by Type
- 4.1 Whole Genome Resequencing Service Type Introduction
- 4.1.1 Human Whole Genome Resequencing
- 4.1.2 Animal Whole Genome Resequencing
- 4.1.3 Plant Whole Genome Resequencing
- 4.2 Global Whole Genome Resequencing Service Sales Value by Type
- 4.2.1 Global Whole Genome Resequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Whole Genome Resequencing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Whole Genome Resequencing Service Sales Value Share by Type (2021-2032)
5 Whole Genome Resequencing Service Market by Application
- 5.1 Whole Genome Resequencing Service Application Introduction
- 5.1.1 Evolutionary Studies
- 5.1.2 Molecule Breeding
- 5.1.3 Physiological Mechanism
- 5.2 Global Whole Genome Resequencing Service Sales Value by Application
- 5.2.1 Global Whole Genome Resequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Whole Genome Resequencing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Whole Genome Resequencing Service Sales Value Share by Application (2021-2032)
6 Whole Genome Resequencing Service Regional Value Analysis
- 6.1 Global Whole Genome Resequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Whole Genome Resequencing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Whole Genome Resequencing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Whole Genome Resequencing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Whole Genome Resequencing Service Sales Value (2021-2032)
- 6.3.2 North America Whole Genome Resequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Whole Genome Resequencing Service Sales Value (2021-2032)
- 6.4.2 Europe Whole Genome Resequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Whole Genome Resequencing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Whole Genome Resequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Whole Genome Resequencing Service Sales Value (2021-2032)
- 6.6.2 South America Whole Genome Resequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Whole Genome Resequencing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Whole Genome Resequencing Service Sales Value Share by Country, 2025 VS 2032
7 Whole Genome Resequencing Service Country-level Value Analysis
- 7.1 Global Whole Genome Resequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Whole Genome Resequencing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Whole Genome Resequencing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Whole Genome Resequencing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Whole Genome Resequencing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Whole Genome Resequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Whole Genome Resequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Macrogen
- 8.1.1 Macrogen Company Information
- 8.1.2 Macrogen Business Overview
- 8.1.3 Macrogen Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Macrogen Whole Genome Resequencing Service Product Portfolio
- 8.1.5 Macrogen Recent Developments
- 8.2 GENEWIZ
- 8.2.1 GENEWIZ Company Information
- 8.2.2 GENEWIZ Business Overview
- 8.2.3 GENEWIZ Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 GENEWIZ Whole Genome Resequencing Service Product Portfolio
- 8.2.5 GENEWIZ Recent Developments
- 8.3 Eurofins Genomics
- 8.3.1 Eurofins Genomics Company Information
- 8.3.2 Eurofins Genomics Business Overview
- 8.3.3 Eurofins Genomics Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Eurofins Genomics Whole Genome Resequencing Service Product Portfolio
- 8.3.5 Eurofins Genomics Recent Developments
- 8.4 GATC Biotech
- 8.4.1 GATC Biotech Company Information
- 8.4.2 GATC Biotech Business Overview
- 8.4.3 GATC Biotech Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 GATC Biotech Whole Genome Resequencing Service Product Portfolio
- 8.4.5 GATC Biotech Recent Developments
- 8.5 Otogenetics Corporation
- 8.5.1 Otogenetics Corporation Company Information
- 8.5.2 Otogenetics Corporation Business Overview
- 8.5.3 Otogenetics Corporation Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Otogenetics Corporation Whole Genome Resequencing Service Product Portfolio
- 8.5.5 Otogenetics Corporation Recent Developments
- 8.6 SeqWright
- 8.6.1 SeqWright Company Information
- 8.6.2 SeqWright Business Overview
- 8.6.3 SeqWright Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 SeqWright Whole Genome Resequencing Service Product Portfolio
- 8.6.5 SeqWright Recent Developments
- 8.7 Personalis Inc.
- 8.7.1 Personalis Inc. Company Information
- 8.7.2 Personalis Inc. Business Overview
- 8.7.3 Personalis Inc. Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Personalis Inc. Whole Genome Resequencing Service Product Portfolio
- 8.7.5 Personalis Inc. Recent Developments
- 8.8 Psomagen
- 8.8.1 Psomagen Company Information
- 8.8.2 Psomagen Business Overview
- 8.8.3 Psomagen Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Psomagen Whole Genome Resequencing Service Product Portfolio
- 8.8.5 Psomagen Recent Developments
- 8.9 Illumina
- 8.9.1 Illumina Company Information
- 8.9.2 Illumina Business Overview
- 8.9.3 Illumina Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Illumina Whole Genome Resequencing Service Product Portfolio
- 8.9.5 Illumina Recent Developments
- 8.10 BGI Genomics
- 8.10.1 BGI Genomics Company Information
- 8.10.2 BGI Genomics Business Overview
- 8.10.3 BGI Genomics Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 BGI Genomics Whole Genome Resequencing Service Product Portfolio
- 8.10.5 BGI Genomics Recent Developments
- 8.11 Novogene
- 8.11.1 Novogene Company Information
- 8.11.2 Novogene Business Overview
- 8.11.3 Novogene Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Novogene Whole Genome Resequencing Service Product Portfolio
- 8.11.5 Novogene Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst